Clomipramine Hydrochloride

Verify with FDA CVM →

346 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
346
Total Reports
11
Deaths Reported
320.0%
Death Rate

Active Ingredients

Clomipramine Hydrochloride

Administration Routes

OralUnknown

Species Affected

Dog 222
Unknown 95
Cat 20
Human 9

Most Affected Breeds

Unknown 104
Dog (unknown) 22
Crossbred Canine/dog 15
Retriever - Labrador 15
Pit Bull 12
Domestic Shorthair 12
Beagle 9
Terrier - Jack Russell 8
Shepherd Dog - German 8
Terrier - Yorkshire 7

Most Reported Reactions

Tablets, Abnormal 69
Lack of efficacy - NOS 50
Uncoded sign 46
Lethargy (see also Central nervous system depression in 'Neurological') 34
Other abnormal test result NOS 27
Emesis 25
Elevated alanine aminotransferase (ALT) 24
Vomiting 22
Diarrhoea 18
Behavioural disorder NOS 17
Anorexia 17
Accidental exposure 16

Outcome Breakdown

Outcome Unknown
102 (40.6%)
Recovered/Normal
84 (33.5%)
Ongoing
46 (18.3%)
Recovered with Sequela
8 (3.2%)
Died
6 (2.4%)
Euthanized
5 (2.0%)

Data Summary

Metric Value
Total adverse event reports 346
Reports involving death 11
Case-fatality rate (reported events) 320.0%
Distinct species in reports 4
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Clomipramine Hydrochloride Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 346 adverse event reports referencing Clomipramine Hydrochloride, including 11 reports in which the animal died — a 320.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Clomipramine Hydrochloride. Reported administration routes include Oral, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Clomipramine Hydrochloride reports are Dog (222 reports), Unknown (95 reports), Cat (20 reports), with Dog accounting for the largest share. Within those species, Unknown (104), Dog (unknown) (22), Crossbred Canine/dog (15) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Clomipramine Hydrochloride are Tablets, Abnormal (69), Lack of efficacy - NOS (50), Uncoded sign (46), Lethargy (see also Central nervous system depression in 'Neurological') (34). Of the 251 reports with a coded outcome, Outcome Unknown is the leading category at 40.6%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Clomipramine Hydrochloride.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial